Delapril

DB13312InvestigationalSmall molecule

Delapril is an ACE inhibitor indicated in the treatment of essential hypertension. A medication used to treat high blood pressure.

Chemical structure of Delapril
Mechanism
Curator reviewed
Formula / weight
C26H32N2O5 · 452.551 g/mol (avg)

Resolves to

Compound
UNIIW77UAL9THICAS83435-66-9ChEMBLCHEMBL589583ChEBI135735
Clinical / RWD
ATCC09AA12ATCC09BA12ATCC09BB12
Structure
InChIKeyWOUOLAUOZXOLJQ-MBSDFSHPSA-NSMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2
Targets
P12821ACE

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
848Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
23ContraindicationsEach with its own population and attribute set
Sign in
26Marketed productsAcross 2 countries and 3 labellers
Sign in
3ATC codesIncluding every combination product, plus 11 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Delapril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In